Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arcturus Therapeutics Ltd (ARCT)

Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 189,866
  • Shares Outstanding, K 28,423
  • Annual Sales, $ 82,030 K
  • Annual Income, $ -65,780 K
  • EBIT $ -76 M
  • EBITDA $ -73 M
  • 60-Month Beta 2.40
  • Price/Sales 2.31
  • Price/Cash Flow N/A
  • Price/Book 0.93

Options Overview Details

View History
  • Implied Volatility 146.53% (+23.04%)
  • Historical Volatility 54.83%
  • IV Percentile 82%
  • IV Rank 29.16%
  • IV High 339.05% on 01/02/26
  • IV Low 67.27% on 05/13/25
  • Expected Move (DTE 6) 0.89 (13.36%)
  • Put/Call Vol Ratio 0.15
  • Today's Volume 100
  • Volume Avg (30-Day) 296
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 12,501
  • Open Int (30-Day) 12,073
  • Expected Range 5.79 to 7.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -1.14
  • Number of Estimates 5
  • High Estimate -0.82
  • Low Estimate -1.38
  • Prior Year -0.52
  • Growth Rate Est. (year over year) -119.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.64 +0.60%
on 03/13/26
8.65 -22.77%
on 02/25/26
-0.53 (-7.35%)
since 02/13/26
3-Month
6.01 +11.06%
on 12/31/25
8.65 -22.77%
on 02/25/26
-0.78 (-10.46%)
since 12/12/25
52-Week
5.85 +14.19%
on 11/20/25
24.17 -72.36%
on 10/21/25
-7.22 (-51.94%)
since 03/13/25

Most Recent Stories

More News
Arcturus Therapeutics to Attend Upcoming Investor Conference

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today...

ARCT : 6.68 (-4.57%)
Arcturus Therapeutics: Q4 Earnings Snapshot

Arcturus Therapeutics: Q4 Earnings Snapshot

ARCT : 6.68 (-4.57%)
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress

ARCT-032 (CF) Phase 2 third cohort (28 days, 15 mg) generally safe and well tolerated ARCT-032 permitted to proceed into 12-week Phase 2 study; dosing to begin H1 2026...

ARCT : 6.68 (-4.57%)
Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics...

ARCT : 6.68 (-4.57%)
1 Under-$10 Stock Set to Surge as Much as 963% in 2026

The high price estimate for Arcturus suggests the stock can rally as high as 963%. Is it a far-fetched target?

$SPX : 6,632.19 (-0.61%)
ARCT : 6.68 (-4.57%)
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics...

ARCT : 6.68 (-4.57%)
Arcturus Therapeutics to Attend Upcoming Investor Conference

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics...

ARCT : 6.68 (-4.57%)
Arcturus Therapeutics: Q3 Earnings Snapshot

Arcturus Therapeutics: Q3 Earnings Snapshot

ARCT : 6.68 (-4.57%)
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress

Encouraging CF interim Phase 2 data support continued and expanded trial design 12-week safety and preliminary efficacy study in up to 20 CF participants planned to start...

ARCT : 6.68 (-4.57%)
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm

NEWTOWN, Pa. , Nov. 10, 2025 /PRNewswire/ -- Edelson Lechtzin LLP  is investigating potential violations of the federal securities laws involving Arcturus Therapeutics Holdings Inc. ("Arcturus")...

ARCT : 6.68 (-4.57%)

Business Summary

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as...

See More

Key Turning Points

3rd Resistance Point 7.68
2nd Resistance Point 7.47
1st Resistance Point 7.07
Last Price 6.68
1st Support Level 6.46
2nd Support Level 6.25
3rd Support Level 5.85

See More

52-Week High 24.17
Fibonacci 61.8% 17.17
Fibonacci 50% 15.01
Fibonacci 38.2% 12.85
Last Price 6.68
52-Week Low 5.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar